FAQ

Hodgkin Disease

Known as: Hodgkin's disease NOS, HODGKINS DISEASE SYSTEMIC, Hodgkins Granuloma 
A cancer of the immune system that is marked by the presence of a type of cell called the Reed-Sternberg cell. The two major types of Hodgkin… (More)

Topic mentions per year

Topic mentions per year

1935-2018
010002000300019352017

Related topics

Related topics

49 relations

Narrower (7)

Adult Hodgkin LymphomaHodgkin lymphoma, lymphocyte depletionLymphocyte Rich Classical Hodgkin LymphomaMixed Cellularity Hodgkin Lymphoma
(More)
Atypical lymphocyteAutoimmune Lymphoproliferative SyndromeBleomycinBleomycin Sulfate
(More)

Broader (2)

Lymphoid organ structureLymphoma

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
Hodgkin Disease
Cisplatin
Lymphoma
Cyclophosphamide
radiotherapeutic
Streptozocin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Cerebrospinal Fluid Biomarkers for Huntington's Disease.
Cerebrospinal fluid (CSF) is enriched in brain-derived components and represents an accessible and appealing means of… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Review
2015
Review
2015
Sudden cardiac death in CKD patients
The risk of sudden cardiac death (SCD) is high in chronic kidney disease patients, and it increases with the progression of… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2015
Highly Cited
2015
PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.
BACKGROUND Preclinical studies suggest that Reed-Sternberg cells exploit the programmed death 1 (PD-1) pathway to evade immune… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Frequent mutation of histone modifying genes in non-Hodgkin lymphoma
Follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) are the two most common non-Hodgkin lymphomas (NHLs). Here we… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.
BACKGROUND Despite advances in treatments for Hodgkin's lymphoma, about 20% of patients still die from progressive disease… (More)
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.
Diffuse large B-cell lymphoma (DLBCL), the most common subtype of non-Hodgkin's lymphoma, is clinically heterogeneous: 40% of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1998
Highly Cited
1998
A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.
BACKGROUND Two thirds of patients with advanced Hodgkin's disease are cured with current approaches to treatment. Prediction of… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Breast cancer and other second neoplasms after childhood Hodgkin's disease.
BACKGROUND Patients who survive Hodgkin's disease are at increased risk for second neoplasms. As survival times increase, solid… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
BACKGROUND CHOP is a first-generation, combination-chemotherapy regimen consisting of cyclophosphamide, doxorubicin, vincristine… (More)
Is this relevant?
Highly Cited
1971
Highly Cited
1971
Report of the Committee on Hodgkin's Disease Staging Classification.
Since the Rye classification for staging was produced in 1965, the significance of 2 important observations with major impact on… (More)
Is this relevant?